Christopher Bunick, MD, PhD
Faculty
Associate Professor of Dermatology,
Program in Translational Biomedicine,
Yale University School of Medicine,
New Haven, CT
Disclosure
Advisory Board: AbbVie, Alumis, Apogee, Arcutis, Eli Lilly, Galderma, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Sun Pharma, Takeda, UCB.
Grant/Research Support: AbbVie, Almirall, Apogee, Daiichi Sankyo, LEO Pharma, Ortho Dermatologics, Sun Pharma, Takeda, Timber
Consultant: AbbVie, Almirall, Alumis, Amgen, Apogee, Arcutis, Botanix, Connect BioPharma, Dermavant, Eli Lilly, EPI Health/Novan, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, Teladoc, Triveni, and UCB.